Caretrust Reit Stock News

This article was originally published on TipRanks.com. The post CareTrust Appoints David Sedgwick as CEO; Shares Fall 6.1% appeared first on Smarter Analyst .

CareTrust REIT: Why This 5% Yielder Is A Great Value Buy

CareTrust REIT (NASDAQ:CTRE) was downgraded by Zacks Investment Research from a buy rating to a hold rating in a note issued to investors on Thursday, Zacks.com reports. According to Zacks, CareTrust REIT, Inc. is a real estate investment trust. It is primarily engaged in the ownership, acquisition and leasing of healthcare-related properties. The Company leases []

SAN CLEMENTE, Calif., Dec. 10, 2021 (GLOBE NEWSWIRE) -- The Board of Directors of CareTrust REIT, Inc. (Nasdaq:CTRE) today announced the appointment of David Sedgwick as Chief Executive Officer, to

SAN CLEMENTE, Calif., Dec. 10, 2021 (GLOBE NEWSWIRE) -- The Board of Directors of CareTrust REIT, Inc. (Nasdaq:CTRE) today announced the appointment of David Sedgwick as Chief Executive Officer, to be effective as of January 1, 2022. Mr. Sedgwick will succeed founding Chairman and CEO Greg Stapley, who will continue to serve as CareTrust’s Executive Chairman during an approximately six-month transition period, following which he and his wife Deborah will commence a three-year, full-time volunteer assignment for The Church of Jesus Christ of Latter-day Saints. The Board also announced that Diana M. Laing has been appointed as Lead Independent Director.

Zacks Investment Research cut shares of CareTrust REIT (NASDAQ:CTRE) from a buy rating to a hold rating in a report published on Thursday, Zacks.com reports. According to Zacks, “CareTrust REIT, Inc. is a real estate investment trust. It is primarily engaged in the ownership, acquisition and leasing of healthcare-related properties. The Company leases healthcare facilities […]

CareTrust REIT (NASDAQ:CTRE)s stock had its buy rating reaffirmed by equities research analysts at BMO Capital Markets in a research note issued on Tuesday, Analyst Price Targets reports. They presently have a $25.00 price objective on the real estate investment trusts stock. BMO Capital Markets price target points to a potential upside of 10.38% from []

Favorable demographic trends and good management can be a winning combination.

Favorable demographic trends and good management can be a winning combination.

Shares of CareTrust REIT, Inc. (NASDAQ:CTRE) have been given a consensus rating of Buy by the eight analysts that are currently covering the company, Marketbeat reports. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average 12-month price objective among brokerages that []

CareTrust REIT (NASDAQ:CTRE)s stock had its buy rating reissued by analysts at BMO Capital Markets in a research note issued on Tuesday, TipRanks reports. They presently have a $25.00 target price on the real estate investment trusts stock. BMO Capital Markets price target points to a potential upside of 10.72% from the companys current price. []

Nisa Investment Advisors LLC lowered its position in CareTrust REIT, Inc. (NASDAQ:CTRE) by 2.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 48,799 shares of the real estate investment trusts stock after selling 1,184 shares during the period. Nisa Investment Advisors []

Raymond James Trust N.A. boosted its holdings in shares of CareTrust REIT, Inc. (NASDAQ:CTRE) by 9.5% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 18,271 shares of the real estate investment trusts stock after purchasing an additional 1,581 shares during []